Reshape Lifesciences Inc (RSLS)
0.1681
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
0.1749
+0.01
(+4.05%)
Pre-Market: 09:22
Reshape Lifesciences Revenue (TTM): 8.678M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.678M |
| September 30, 2023 | 9.806M |
| June 30, 2023 | 10.45M |
| March 31, 2023 | 11.09M |
| December 31, 2022 | 11.24M |
| September 30, 2022 | 11.27M |
| June 30, 2022 | 12.18M |
| March 31, 2022 | 12.82M |
| December 31, 2021 | 13.60M |
| September 30, 2021 | 13.66M |
| June 30, 2021 | 13.56M |
| March 31, 2021 | 11.73M |
| December 31, 2020 | 11.30M |
| September 30, 2020 | 12.14M |
| June 30, 2020 | 12.06M |
| March 31, 2020 | 14.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 15.09M |
| September 30, 2019 | 11.49M |
| June 30, 2019 | 7.982M |
| March 31, 2019 | 3.542M |
| December 31, 2018 | 0.607M |
| September 30, 2018 | 0.233M |
| June 30, 2018 | 0.5851M |
| March 31, 2018 | 0.6681M |
| December 31, 2017 | 0.5692M |
| September 30, 2017 | 0.635M |
| June 30, 2017 | 0.5718M |
| March 31, 2017 | 0.7547M |
| December 31, 2016 | 0.7867M |
| September 30, 2016 | 0.7938M |
| June 30, 2016 | 0.561M |
| March 31, 2016 | 0.364M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
7.982M
Minimum
Jun 2019
15.09M
Maximum
Dec 2019
11.84M
Average
11.73M
Median
Mar 2021
Revenue (TTM) Benchmarks
| Cutera Inc | 230.18M |
| Dynatronics Corp | 35.18M |
| Stereotaxis Inc | 26.77M |
| Electromed Inc | 51.69M |
| Myomo Inc | 19.24M |